Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Bar-Tana

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Trends in Endocrinology and Metabolism: TEM|January 30, 2023
mTORC1 syndrome (TorS): unified paradigm for diabetes/metabolic syndromeJacob Bar-Tana
Diabetes/Metabolism Research and Reviews|August 24, 2023
TorS - Reframing a rational for type 2 diabetes treatmentJacob Bar-Tana
Current Opinion in Investigational Drugs (London, England : 2000)|October 27, 2004
Hypolipidemia induced by PPARalpha agonists: HNF-4alpha as an alternative to PPARalphaJacob Bar-Tana
Reviews in Endocrine & Metabolic Disorders|March 5, 2020
Type 2 diabetes - unmet need, unresolved pathogenesis, mTORC1-centric paradigmJacob Bar-Tana
Frontiers in Endocrinology|October 18, 2021
Insulin Resistance, Secretion and Clearance -Taming the Three Effector Encounter of Type 2 DiabetesJacob Bar-Tana
Journal of Translational Medicine|March 10, 2025
mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAISJacob Bar-Tana
The Biochemical Journal|August 18, 2004
Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinaseMyriam Bronner, Rachel Hertz, Jacob Bar-Tana
Endocrine Reviews|August 24, 2013
Thyroid hormone, thyromimetics, and metabolic efficiencyEinav Yehuda-Shnaidman, Bella Kalderon, Jacob Bar-Tana
Endocrinology|February 5, 2005
Modulation of mitochondrial transition pore components by thyroid hormoneEinav Yehuda-Shnaidman, Bella Kalderon, Jacob Bar-Tana
American Journal of Physiology. Endocrinology and Metabolism|March 9, 2017
Insulin sensitizer prevents and ameliorates experimental type 1 diabetesMichael Valitsky, Amnon Hoffman, Terry Unterman, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Trends in Endocrinology and Metabolism: TEM|January 30, 2023
mTORC1 syndrome (TorS): unified paradigm for diabetes/metabolic syndromeJacob Bar-Tana
Diabetes/Metabolism Research and Reviews|August 24, 2023
TorS - Reframing a rational for type 2 diabetes treatmentJacob Bar-Tana
Current Opinion in Investigational Drugs (London, England : 2000)|October 27, 2004
Hypolipidemia induced by PPARalpha agonists: HNF-4alpha as an alternative to PPARalphaJacob Bar-Tana
Reviews in Endocrine & Metabolic Disorders|March 5, 2020
Type 2 diabetes - unmet need, unresolved pathogenesis, mTORC1-centric paradigmJacob Bar-Tana
Frontiers in Endocrinology|October 18, 2021
Insulin Resistance, Secretion and Clearance -Taming the Three Effector Encounter of Type 2 DiabetesJacob Bar-Tana
Journal of Translational Medicine|March 10, 2025
mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAISJacob Bar-Tana
The Biochemical Journal|August 18, 2004
Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinaseMyriam Bronner, Rachel Hertz, Jacob Bar-Tana
Endocrine Reviews|August 24, 2013
Thyroid hormone, thyromimetics, and metabolic efficiencyEinav Yehuda-Shnaidman, Bella Kalderon, Jacob Bar-Tana
Endocrinology|February 5, 2005
Modulation of mitochondrial transition pore components by thyroid hormoneEinav Yehuda-Shnaidman, Bella Kalderon, Jacob Bar-Tana
American Journal of Physiology. Endocrinology and Metabolism|March 9, 2017
Insulin sensitizer prevents and ameliorates experimental type 1 diabetesMichael Valitsky, Amnon Hoffman, Terry Unterman, et al.
Pageof 4